Zachariah P. Zachariah, M.D., Strategic Advisory Board
Dr. Zachariah is a former Director of Ivax Corporation (together with its Chairman Dr. Phil Frost), a marketer of a patented asthma inhaler called Easi-Breathe and other branded respiratory drugs, which was acquired by Teva Pharmaceutical Industries (NYSE: TEVA) for $7.4 billion. Dr. Zachariah is a prominent cardiologist, philanthropist, humanitarian, business and community leader and has been in Private Practice of Clinical and Interventional Cardiology at Holy Cross Hospital, Fort Lauderdale, since 1976. Dr. Zachariah is the President of the Fort Lauderdale Heart Institute, serves as the Section Chief of Cardiology at Holy Cross Hospital, and is currently a Voluntary Clinical Professor of Medicine at the University of Miami School of Medicine.
Dr. Zachariah has served as a member of the Board of Trustees of Nova Southeastern University since 1993; Treasurer and Member of the Board of the Foundation for Excellence in Education; a member and former President of the Florida Council on Economic Education, a not-for-profit organization that educates students in kindergarten through high school on economic principles to better prepare them for personal and professional success in our free enterprise system; and he is a member of The Florida Council of 100, a statewide organization of business leaders who advise the Governor on issues of public policy. Dr. Zachariah currently serves on the Florida Board of Medicine, having previously served from 1988 to 1992 and again from 1998 and 2002. He served as Chairman of the Board of Medicine from 1990-1992, from 2001-2002 and again from 2013-2014. From 2003-2010, he served on the Florida Board of Governors which oversees all public universities in the State of Florida; and was Chairman of the Governor’s Task Force on the Obesity Epidemic in 2003. He has also served as the President of the American Heart Association – Florida Affiliate and as a Member of the Board of Governors for the Florida Medical Association.
Dr. Zachariah has also served as a member of the National Heart, Lung and Blood Advisory Council of the National Institutes of Health from 1990 – 1993, under President George H.W. Bush, and as a member of the President’s Advisory Commission on Asian American and Pacific Islanders in 2001 – 2005 under President George W. Bush. He also served as Special Advisor to the Secretary of Health and Human Services at the World Health Organization in Geneva, Switzerland in May 2002. Dr. Zachariah has received numerous awards for his humanitarian work, community service, advocacy on behalf of children and his leadership in public health. He was awarded the “Ellis Island Medal of Honor” in 1988; the “Ellis Island American Legends Award” from the National Ethnic Coalition of Organizations Foundations, Inc.; in 2000 the “George Washington Honor Medal” from the Freedoms Foundation at Valley Forge; and the “Torch of Liberty Award” from the American Jewish Congress. Three Florida Governors, have proclaimed a “Zachariah P. Zachariah Day” in the State of Florida. Dr. Zachariah completed his residency in internal medicine at St. Joseph’s Hospital and Medical Center in Paterson, New Jersey, and had a Fellowship in Cardiology at the Cleveland Clinic Educational Foundation in Cleveland, Ohio. He has performed in excess of 25,000 heart procedures since he started his career at Holy Cross Hospital.
Vincent Mosesso, Jr., M.D., FACEP, Strategic Advisory Board
Dr. Mosesso is a nationally renowned emergency physician and is the Medical Director for Pre-hospital Care at the University of Pittsburgh Medical Center (UPMC) for over 19 years. He also serves as Professor of Emergency Medicine at the University of Pittsburgh School of Medicine for the past 24 years. Dr. Mosesso is also the Medical Director and Founding Board Member of the Sudden Cardiac Arrest Association (SCAA). SCAA identifies and unites survivors, those at risk of sudden cardiac arrest, as well as others who are interested in being advocates on SCAA issues in their communities and beyond. SCAA membership is dedicated to promoting solutions to prevent sudden cardiac death, including increased awareness, immediate bystander action, public access to defibrillation (PAD), cardiovascular disease prevention, and access to preventative therapies.
Dr. Mosesso is a fellow of the American College of Emergency Physicians and is a member the Society for Academic Emergency Medicine, the American Heart Association and the American Stroke Association – where he serves Board of Directors for the Allegheny Division - and the National Association of Emergency Medical Services Physicians. Dr. Mosesso has also served as Associate Medical Director for the City of Pittsburgh, Bureau of EMS for the past 23 years. In 1998, he was named "Physician of the Year" by the Pennsylvania Emergency Health Services Council and he has authored or co-authored more than 40 peer-reviewed scientific manuscripts and textbook chapters related to emergency medicine.
Dr. Joseph M. Chalil, MD, MBA, FACHE, Strategic Advisory Board
Dr. Chalil (42) is a Physician and Executive at Boehringer Ingelheim, the world's largest privately held pharmaceutical company. Headquartered in Ingelheim, Germany, Boehringer Ingelheim operates globally with 146 affiliates and a total of more than 47,700 employees. In 2014, Boehringer Ingelheim achieved net sales of about 13.3 billion euros. R&D expenditure corresponds to 19.9 per cent of its net sales.
In addition to his responsibilities at Boehringer Ingelheim, Dr. Chalil is the Chairman of Global Clinical Research and Trial Network of the American Association of Physicians of Indian Origin (AAPI) and has served as Scientific Advisor to the AAPI for the past five years. AAPI is the second largest physician organization in the US second only to American Medical Association, and the largest ethnic medical organization in the country.
A veteran of the United States Navy Medical Corps, Dr. Chalil is also board certified in healthcare management, and has been awarded Fellowship by the Americans College of Healthcare Executives, an international professional society of more than 40,000 healthcare executives who lead hospitals, healthcare systems and other healthcare organizations.
Dr. Chalil is an expert in US Healthcare policy and a strong advocate for patient centered care, and has also served as an advisor to various national political campaigns on healthcare issues. Dr. Chalil completed his higher studies in University of Medicine and Dentistry of New Jersey, Davenport University and JJM Medical College. He has been a visiting Professor at various Universities and serves on various company Boards.
Dr. Chalil holds three US Patents, and his research includes Clinical Trial Management in Cystic Fibrosis, Multiple Myeloma, and publications in American Journal of Respiratory and Critical Care Medicine. He was the recipient of the 2013 Outstanding 50 Asian Americans in Business Award. The American Association of Cardiologists of Indian Origin (AACIO) honored Dr. Chalil for his achievements in the field of Cardiology in 2013. Dr. Chalil is also the honored recipient of the prestigious 2015 AAPI Presidential Award.
Christopher Kaplan, M.Sc, Strategic Advisory Board
Mr. Kaplan is currently Senior Vice President and Global Head of Diabetes for Sanofi, a French pharmaceutical company with $38 Billion in sales. Mr. Kaplan heads the worldwide diabetes franchise with a $7 Billion budget.
Prior to Sanofi, Mr. Kaplan spent two years with Boehringer Ingelheim as Senior Vice President and Chief Marketing Officer. That followed 12 years at Novartis in both the US and Europe. Mr. Kaplan began at Novartis as Global Head of the Cardiovascular and Metabolic Business Franchise in Basel Switzerland, then moved to Head the Nordic Region Cluster and General Manager in Stockholm Sweden, and then became Head of Northern and Central Europe and Region Europe Marketing & Sales back in Basel. He returned to the US as President, Cardiovascular & Metabolic Operating Unit, in E. Hanover New Jersey, and then served as President and General Manager of the East Operating Unit, also in E. Hanover.
Mr. Kaplan started his pharmaceutical career at Bristol-Myers Squibb Company. He moved quickly through various roles in US sales and sales management and then in US marketing. He began his international experience in Paris as the Cardiovascular Marketing Director for Europe and then progressed to his last role at Bristol-Myers Squibb as Marketing and Sales Director in Rome, Italy.
Mr. Kaplan is a graduate of Columbia University, holds a Masters of Science Degree from the University of Pennsylvania, and undertook post-graduate studies at INSEAD, Fontainebleu, France. He has also completed executive education programs at Harvard, Wharton and the London Business School.
Thomas D. Franklin, Jr., Ph.D, Strategic Advisory Board
Dr. Franklin is a healthcare veteran with four decades experience in medical devices, medical research, technology assessment, regulatory strategy, and product development, especially in the cardiovascular, ultrasound (both diagnostic and therapeutic), orthopedic and spine, and minimally invasive technology expertise areas.
Dr. Franklin currently serves as Senior Scientific Advisor to the North Texas Enterprise Center for Medical Technology, Inc. (NTEC) for the past 12 years. In that role he assists with technology assessment and provides scientific guidance to medical device companies at NTEC, a business accelerator focused on medical devices and clinical information technologies. He has also served as the Chairman of the Scientific Advisory Board for the National PKU Alliance, which guides the evaluations and recommendations of research proposals seeking the cure for PKU and funding post-doctoral fellowships in PKU studies.
From 1998 through 2003 Dr. Franklin Executive served as the Director and President for the Texas Health Research Institute (THRI). THRI was a member organization of Texas Health Resources (THR), a 13-hospital non-profit healthcare system which includes acute-care hospitals, medical research institute, and geriatric care and living facility. From 1990 through 2003 he served as President of the Texas Back Institute Research Foundation. From 1982 through 1990 Dr. Franklin served as President and Executive Director for the Indianapolis Center for Advanced Research. He has also served as a tenured faculty member in the Department of Radiology at the Indiana University School of Medicine in Indianapolis.
Dr. Franklin holds a B.S. Biology from Wake Forest University, an M.S. in Cardiovascular Physiology from the Wake Forest University, Bowman Gray School of Medicine, and a Ph.D in Cardiovascular Physiology & Biophysics from the University of Illinois at Urbana-Champaign.
James R. Winn, M.D., Strategic Advisory Board
Dr. Winn has over 36 years experience in the healthcare industry, having served in a policy role as well as a general practitioner. Dr. Winn served for 11 years as the Executive Director of the Federation of State Medical Boards (FSMB) of the United States. FSMB is a national non-profit organization representing the 70 medical boards of the United States and its territories, and whose mission is to continuously improve the quality, safety and integrity of health care through developing and promoting high standards for physician licensure and practice.
Jonathan E. Burke, D.M.D., Strategic Advisory Board
Dr. Burke is a foremost Oral and Maxillofacial surgeon and has served as the team oral and maxillofacial surgeon for the Philadelphia Flyers and Phantoms professional hockey clubs since 1994. He also significant experience in hyperbaric oxygen therapy and received an Attending Hyperbaric Medicine Certificate in 1996.
Dr. Burke served as Assistant Professor of Surgery, University of Medicine and Dentistry of New Jersey Rutgers Medical School and the Robert Wood Johnson Medical School in Camden, New Jersey, training Oral and Maxillofacial Surgery residents for 10 years before returning to private practice.
Dr. Burke graduated Cum Laude and Rho Chi from Temple University School of Pharmacy in 1985. He received his DMD degree and graduated Cum Laude and Omicron Kappa Upsilon in 1989 from Temple University School of Dentistry. He then completed a four-year surgical residency in Oral & Maxillofacial Surgery at Temple University Hospital including training at Pennsylvania Hospital, St. Christopher Hospital for Children, and Cooper Hospital University Medical Center.
R. Dean White, D.D.S., M.S., Strategic Advisory Board
Dr. White is a past President of the American Board of Oral & Maxillofacial Surgeons, and is one of the foremost Oral & Maxillofacial surgeons in the US, with over 30 years experience in private practice. For the past 6 years Dr. White was Principal Dean White Consulting, providing education and consultation services for medical staff leadership, management of disruptive behavior and issues of the aging physician and boundary violations by physicians.
Dr. White retired from private practice in 2002 to assume a position with Texas Health Harris Methodist Hospital as Medical Staff Advisor with responsibilities of orientation of all new medical staff physicians, as well as leadership training of medical staff leaders, mentoring and coaching, and administrative oversight of the Physician Health Committee.
Dr. White earned his DDS and MS degrees in Oral and Maxillofacial Surgery, as well as an MS in Biomedical Sciences from the University of Texas Health Science Center at Houston.